Success Stories

What treatment can look like

What GLP-1 treatment journeys can look like, based on clinical trial outcomes and illustrative patient scenarios.

15-22%
Body weight reduction (SURMOUNT-1 trial)
72 wks
Trial duration
2.5–15mg
Dose range

Photos are illustrative and do not represent actual patients. All stories are based on typical treatment outcomes.

Illustrative photo — not a real patient-18 kg
-18 kg
8 months · Tirzepatide

Illustrative scenario: a structured plan, regular check-ins, and consistent treatment can support meaningful weight reduction over several months.

Illustrative scenario · Not a real patient
Started at 96 kg BMI 33.2 → 26.9 Tirzepatide 10mg
* Illustrative example based on typical treatment patterns. Not a real patient.
Illustrative photo — not a real patient-22 kg
-22 kg
10 months · Tirzepatide

Illustrative scenario: some people may see weight reduction alongside improvements in health markers when treatment is combined with ongoing lifestyle support.

Illustrative scenario · Not a real patient
Started at 112 kg BMI 36.1 → 29.0 Metabolic markers improved
* Illustrative example based on typical treatment patterns. Not a real patient.
Illustrative photo — not a real patient-12 kg
-12 kg
6 months · Tirzepatide

Illustrative scenario: support materials can help people feel more prepared for weekly injections and early adjustment periods.

Illustrative scenario · Not a real patient
Started at 88 kg BMI 31.4 → 27.1 Hormonal health improvement
* Illustrative example based on typical treatment patterns. Not a real patient.
Illustrative photo — not a real patient-15 kg
-15 kg
7 months · Tirzepatide

Illustrative scenario: reduced weight may make everyday movement feel easier for some people, though outcomes vary by person.

Illustrative scenario · Not a real patient
Started at 104 kg BMI 34.8 → 29.8 Blood pressure improved
* Illustrative example based on typical treatment patterns. Not a real patient.
Illustrative photo — not a real patient-12 kg
-12 kg
6 months · Tirzepatide

Illustrative scenario: early side effects can affect adherence, so people should use the support resources and seek urgent care for severe symptoms.

Illustrative scenario · Not a real patient
Started at 98 kg BMI 32.5 → 28.5 Early side effects managed well
* Illustrative example based on typical treatment patterns. Not a real patient.

Know someone who could benefit? Share these stories.

Share on WhatsApp

Disclaimer: The patient stories on this page are illustrative examples based on outcomes observed in published clinical trials. They do not represent specific Second Cure patients. Individual results vary, and Tirzepatide is not suitable for everyone.

Start your journey today

Take the 3-5 minute assessment to see if Tirzepatide could be the right next step for you.

Start your assessment →